Events & presentations
Upcoming events
-
Zealand Pharma Interim Report Q3 2024
Thursday, November 7 at 2:00 pm CET (8:00 am ET)
- Webcast
- ADD TO CALENDAR
Past events
-
2024 Cantor Global Healthcare Conference
- Webcast
-
Zealand Pharma Interim Report H1 2024
- Webcast
-
Zealand Pharma topline results for Phase 1b trial of petrelintide
- Webcast
-
Goldman Sachs 45th Annual Global Healthcare Conference
- Webcast
-
Jefferies Global Healthcare Conference 2024
- Webcast
-
Zealand Pharma Interim Report Q1 2024
- Webcast
-
TD Cowen’s 44th Annual Health Care Conference in Boston, MA
- Webcast
-
Zealand Pharma Annual Report 2023
- Webcast
-
Zealand Pharma at Goldman Sachs Healthcare C-Suite Unscripted Conference
- Webcast
-
Zealand Pharma’s Obesity R&D Event
- Webcast
-
Zealand Pharma Interim Report Q3 2023
- Webcast
-
Jefferies London Healthcare Conference
- Webcast
-
Morgan Stanley 21st Annual Global Healthcare Conference
- Webcast
-
Zealand Pharma Interim Report H1 2023
- Webcast
-
Goldman Sachs 44th Annual Global Healthcare Conference
-
Jefferies Global Healthcare Conference
- Webcast
-
Zealand Pharma Interim Report Q1 2023
- Webcast
-
22nd Annual Needham Virtual Healthcare Conference
- Webcast
-
-
Evercore ISI Annual HealthCONx Conference
- Webcast
-
Jefferies London Healthcare Conference 2022
- Webcast
-
Zealand Pharma Interim Report Q3 2022
- Webcast
-
Obesity Week 2022
- More details
-
Conference Call to Discuss Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)
-
European Society for Paediatric Endocrinology 2022
-
Morgan Stanley 20th Annual Global Healthcare Conference
-
Zealand Pharma Interim Report H1 2022
-
Goldman Sachs Global Healthcare Conference
-
Jefferies 2022 Global Healthcare Conference
- Webcast
-
Annual American Diabetes Association Scientific Sessions
- More details
-
Zealand Pharma Interim Report Q1 2022
-
21st Annual Needham Virtual Healthcare Conference
- Webcast
-
Zealand Pharma Corporate Update Conference Call
- Dial-in
-
-
H.C. Wainwright BIOCONNECT 2022 Conference
Obesity R&D event
Featured Event
We hosted an event for investors to discuss the scientific rationale and clinical potential of our differentiated product candidates targeting obesity. Speakers at the event were Adam Steensberg, our CEO; and David Kendall, our CMO and Head of R&D, joined by three leading external experts.